Acknowledgements
ONCOLOGY
We thank all the patients and families who made this trial possible, clinical study teams and data and safety monitoring members. This trial was funded by Taiho Oncology, Inc. and Taiho Pharmaceuticals Co., Ltd. This analysis was funded by Taiho Oncology, Inc. Professional medical writing and editorial assistance were provided by Vasupradha Vethantham, PhD, and Kathleen Blake, PhD, of Ashfield Medcomms, an Inizio company, funded by Taiho Oncology, Inc.